GET H2 ergänzt BMWE-Impulspapier um Forderungen aus der Praxis

Ein Dokument

Münster (ots)

Basierend auf Erfahrungen aus der Praxis haben die Partner der Initiative GET H2 in einem 7-Punkte-Papier Maßnahmen aufgelistet, mit denen die Bremsen beim Wasserstoffhochlauf gelöst werden können. Diese sieben Punkte sind eine Einordnung und Ergänzung des Impulspapiers zum Wasserstoffhochlauf, das am 20. Oktober durch das Bundesministerium für Wirtschaft und Energie (BMWE) veröffentlicht wurde.

Die GET H2 Partner begrüßen grundlegend, dass das BMWE mit seinem Impulspapier die Unterstützung des Wasserstoffhochlaufs wieder aufgegriffen hat. "Die Richtung stimmt", sind sich die Partner einig. "Wir knüpfen an diesen Punkten an und liefern basierend auf unseren praktischen Erfahrungen Hinweise für eine konkretere Ausgestaltung der Maßnahmen." Das Paper weißt unter anderem auf die Dringlichkeit in der Umsetzung wichtiger regulatorischer Maßnahmen wie die weiterhin ausstehende Umsetzung der EU Binnenmarktrichtlinie Gas und Wasserstoff im Rahmen einer Novelle des Energiewirtschaftsgesetzes (EnWG) hin.

Das Besondere an dem GET H2 Paper: "Die Forderungen basieren auf konkreten Erfahrungen, die mit der Umsetzung von Projekten entlang der gesamten H2-Wertschöpfungskette gemacht wurden", so die Partner der Initiative. Im August 2026 haben sie mit dem GET H2 Nukleus das erste voll integrierte Wasserstoffcluster in Betrieb genommen, in dem erneuerbarer Wasserstoff aus einer 100 MW Elektrolyse in Lingen über eine Leitungsinfrastruktur zum Chemiepark Marl transportiert wird. Die in dem Paper aufgeführten Maßnahmen zur Senkung der Erzeugungskosten von erneuerbarem Wasserstoff, zur Sicherung der Transportinfrastruktur sowie zur Unterstützung der Nachfrage sind die Voraussetzung, um die Investitionssicherheit für weitere Projekte dieser Art zu schaffen.

Die zentralen Aspekte des 7-Punkte-Papiers:

- RFNBO-Kriterien pragmatisch reformieren, Netzentgeltregime klären

- Zertifizierungssystem stärken - Handel von physischem Wasserstoff und Herkunftseigenschaft entkoppeln

- Import beschleunigen - heimische Wettbewerbsfähigkeit sichern

- Kernnetz absichern, Verteilnetze als eigenständige Priorität angehen

- Speicher als systemrelevante Infrastruktur sofort anschieben

- Erzeugung und Nachfrage zusammenbringen - Nachfrageanreize neu ordnen

- RED-III-Transportquote: Bestandsschutz sichern

Das Paper steht auf der Website von GET H2 zum Download zur Verfügung:

https://www.get-h2.de/fakten-und-studien/

Pressekontakt:

Nowega GmbH

Kai Tenzer

info@get-h2.de

0251 60998-345

Original-Content von: Nowega GmbH, übermittelt durch news aktuell

Thomas Goiser Projektkommunikation e.U.

„Vom Gehen und Werden“ – Rebecca Gischel macht den Kreislauf des Lebens zum Kunstprojekt

München (ots)

Stimmungsvolle Kunstaktion bei Herrmannsdorfer Landwerkstätten am Viktualienmarkt in München

Was passiert, wenn sich Kunst, Ort und Leben voneinander berühren lassen? Von der Geburt der Ferkel über ihr Leben im Wald bis zu ihrem Tod und unserer Nahrung. Ein ewiger Kreislauf.

Darauf hat sich die Münchner Künstlerin Rebecca Gischel über mehrere Monate eingelassen und ihre Inspiration aus einem Aufenthalt bei Herrmannsdorfer in Glonn in einem großformatigen Bild verarbeitet.

Am Donnerstag (29.10.) präsentierte sie gemeinsam mit Geschäftsführer Karl Schweisfurth das Projekt und ihr Werk im Bistro von Herrmannsdorfer am Münchner Viktualienmarkt. Mit rund 80 Gästen wurde das Leben in einem Ritual zelebriert und im Zuge dessen auch Schinken verkostet, der über mehrere Wochen im gleichen Raum wie das Bild gereift war. Saxophonmusik von Matthieu Bordenave und die Moderation von Dr. Thomas Nesseler trugen zur besonders stimmungsvollen Atmosphäre bei.

Weitere Infos zum Projekt sind hier zu finden, Fotos zur Veranstaltung hier.

Stationen zwischen Glonn und München – Kunstwerk kehrt nun zurück

Bei Herrmannsdorfer in Glonn erlebte Gischel im Juni Geburt und Tod hautnah mit; in der Folge gestaltete sie das 3*2 Meter große Triptychon. Im September kehrte das Bild ein erstes Mal zur Reifung nach Glonn zurück, nun wurde es in München öffentlich präsentiert. Demnächst wird es dauerhaft im „ Wirtshaus zum Schweinsbräu“ bei Herrmannsdorfer zu sehen sein.

Gischel erklärt zum Projekt: „In einem ewigen Kreislauf ist unser Sein unausweichlich auf anderes Sein angewiesen. Meine Antwort darauf lautet daher: Bewusstheit und unbedingte Wertschätzung allem Leben gegenüber.“

Seit ihrer Gründung vor 40 Jahren weisen die Herrmannsdorfer Landwerkstätten eine besonders starke Verankerung in der Kunst auf. Gründer Karl Ludwig Schweisfurthwar mit Joseph Beuys persönlich gut bekannt. Dessen Ideen beeinflussten auch die Gestaltung des Unternehmens.

Pressekontakt:

Thomas Goiser

E-Mail: thomas@goiser.at

Original-Content von: Thomas Goiser Projektkommunikation e.U., übermittelt durch news aktuell

Ruth Moschner ist Botschafterin des neuen Musicals "KICK LIKE A WOMAN"

"Diese Geschichte verdient die große Bühne"

Köln (ots)

TV-Moderatorin Ruth Moschner setzt ein starkes Zeichen für Frauen im Sport: Als Botschafterin des Musicals "KICK LIKE A WOMAN" wird sie die VIP-Premiere am 12. November in Köln persönlich begleiten - und damit die Frauen feiern, die sich gegen alle Widerstände durchgesetzt und Sportgeschichte geschrieben haben.

Eine Botschafterin für weibliche Vorbilder - Probenbesuch in Köln

Die Botschafterin ist nicht nur prominentes Gesicht des Musicals, sondern vor allem leidenschaftliche Mitstreiterin seiner Botschaft. Nach ihrem Besuch bei den Proben freut sich die Moderatorin und Entertainerin darauf, die Premiere am 12. November persönlich zu begleiten. Ihr Engagement ist eng mit ihrem Anliegen verknüpft, starke weibliche Rollenvorbilder sichtbarer zu machen: "Weibliche Vorbilder gab es schon immer. Es wird Zeit, die Scheinwerfer auf sie zu richten und sie zum Strahlen zu bringen! Diese Geschichte ist ein klares JA dafür, dass Frauen sich keine Grenzen setzen lassen sollten. Lasst uns diesen Weg gemeinsam gehen", sagt Moschner und führt weiter aus "diese Pionierinnen des Frauenfußballs haben nicht nur die Fußballwelt verändert - sie sind Inspiration weit über den Sport hinaus."

Die Geschichte dahinter

"KICK LIKE A WOMAN" basiert auf der wahren Geschichte: Anfang der 1980er Jahre wurde Frauenfußball in Westdeutschland vom Deutschen Fußball-Bund kaum ernst genommen. Als Taiwan die erste - inoffizielle - Frauenfußball-Weltmeisterschaft ausrichtet, sagte der Verband ab. Die Spielerinnen der SSG 09 Bergisch Gladbach ließen sich nicht aufhalten: Sie organisierten Reise und Teilnahme selbst, spielten in Taipeh das Turnier ihres Lebens - und kehrten als Weltmeisterinnen zurück.

Das Musical verbindet diese reale Vorlage mit einer fiktionalen Geschichte und macht aus der historischen Vorlage ein berührendes und begeisterndes Mutmacher-Stück.

"Jetzt bekommt diese Geschichte die große Bühne, die sie verdient"

Die Botschafterin sieht in "KICK LIKE A WOMAN" eine Geschichte, die auch heute noch dringend erzählt werden muss: "Jetzt bekommt diese Geschichte endlich die große Bühne, die sie verdient. Ich bin allen Frauen so unendlich dankbar, dass sie Türen aufgestoßen haben!"

Dabei geht es ihr nicht nur um eine Rückschau, sondern um konkrete gesellschaftliche Veränderungen: "Mein Wunsch ist es, dass Frauen irgendwann eben nicht mehr stark sein MÜSSEN, sondern dass wir frei entscheiden dürfen, welchen Weg wir gehen.

Ohne Gender-Pay-Gap, gesellschaftlichen Ausschluss und überhöhten Leistungsdruck. Dafür braucht es inspirierende Erfolgsgeschichten wie diese hier."

Produzent Frank Blase: "Sie steht hundertprozentig hinter der Story"

apiro Entertainment Produzent Frank Blase sieht in der Botschafterin eine ideale Partnerin für das Projekt. "Mit 'KICK LIKE A WOMAN' erzählen wir von Frauen, die sich mit einem wahnsinnigen Kraftakt gegen alle Widerstände durchgesetzt haben", so Blase. "Ruth Moschner steht hundertprozentig hinter der Story und dem, was sie erzählt. Die Verbindung zwischen ihrem Engagement und dem Kern unseres Musicals könnte passender kaum sein."

Fotos: Die mitgelieferten Bilder können im Zusammenhang mit der Meldung kostenfrei unter Nennung des Fotocredits genutzt werden.Download aller Motve unter: https://we.tl/t-7gV5kvq9BqM8HpBo

Informationen zur Produktion

Spielzeit:12. November 2026 bis 11. April 2027

Ort: Depot 1, Schanzenstraße 6 - 20, 51063 Köln-Mülheim

Tickets: unter www.kicklikeawoman.de

Pressekontakt:

Public Cologne GmbH

Gertrudenstraße 9

50667 Köln

Tel: 0221-2720266

info@publiccologne.de

Original-Content von: apiro Entertainment GmbH, übermittelt durch news aktuell

„Der große Stasi-Leak – Helden oder Verräter?“: Neue MDR-Dokumentation rekonstruiert die Veröffentlichung der Hallenser Stasi-Liste

Leipzig (ots)

Es ist einer der größten Datenskandale der Nachwendezeit: 1992 kursiert in Sachsen-Anhalt eine anonyme Liste mit den Namen von 4.500 mutmaßlichen Stasi-Informantinnen und -Informanten aus Halle/Saale. Wer hinter der Veröffentlichung steckt, blieb jahrzehntelang geheim. In der neuen MDR-Dokumentation für ARD History „Der große Stasi-Leak – Helden oder Verräter?“ treten die Urheber der Liste nach über 35 Jahren zum ersten Mal vor die Kamera und erzählen ihre Geschichte. Die Dokumentation ist ab sofort in der ARD Mediathek verfügbar und am 10. November um 20.15 Uhr im MDR-Fernsehen zu sehen.

In der Dokumentation erzählen die Protagonisten von ihrem Entschluss, die Namen mutmaßlicher Stasi-Mitarbeiterinnen und -Mitarbeiter öffentlich zu machen, von geschmuggelten Mikrofilmen, geheimen Verstecken und konspirativen Aktionen. Zugleich berichten sie von den Zweifeln, die sie bis heute begleiten: War ihr Handeln ein notwendiger Beitrag zur Aufarbeitung der DDR-Vergangenheit oder ein folgenschwerer Rechtsbruch?

„Der große Stasi-Leak – Helden oder Verräter?“ rekonstruiert die Ereignisse rund um die Veröffentlichung der sogenannten Hallenser IM-Liste und legt bislang unbekannte Hintergründe offen. Dabei entwickelt sich der Film zu einem zeitgeschichtlichen True-Crime- und Spionagefall, der Fragen nach Wahrheit, Verantwortung und den Grenzen zivilen Ungehorsams aufwirft.

Neben der spektakulären Geschichte des Leaks beleuchtet die Dokumentation auch die rechtlichen und gesellschaftlichen Folgen der Veröffentlichung. Die damals anonym handelnden Beteiligten setzen sich mit den Konsequenzen ihres Handelns auseinander und reflektieren, welche Auswirkungen ihre Entscheidung auf Betroffene, die Öffentlichkeit und die Aufarbeitung der DDR-Geschichte hatte.

Die Dokumentation zeichnet damit das Bild eines außergewöhnlichen Kapitels der deutschen Zeitgeschichte und stellt eine Frage, die bis heute aktuell ist: Wie weit darf man gehen, um Transparenz zu schaffen und vermeintliche Wahrheiten ans Licht zu bringen?

„Der große Stasi-Leak – Helden oder Verräter?“ ist eine Produktion von flow MEDIA im Auftrag des MDR.

Pressekontakt:

MDR, Kommunikations- und Mediendesk, E-Mail:

kommunikation-desk@mdr.de

Original-Content von: MDR Mitteldeutscher Rundfunk, übermittelt durch news aktuell

Xinhua Silk Road: Carnival held in SW China's Jinghong City to promote people-to-people exchanges

BEIJING, Oct. 30, 2026 /PRNewswire/ -- Lancang-Mekong Treasures Carnival, a key supporting event of the 14th Culture and Art Festival of Countries in the Lancang-Mekong River Basin, kicked off on October 28 in Jinghong City, capital of Xishuangbanna Dai Autonomous Prefecture, southwest China's Yunnan Province.

Under the theme of "encounter the Lancang-Mekong, encounter fine treasures," the carnival has seen more than 100 booths set up along the 1.2-kilometer riverbank of the Lancang River.

The booths have been divided into six sections including tea, beans, crafts, fruits, rainforest food and rainforest stays, with travel photography and cultural creative scenarios set up.

The carnival has combined industrial promotion, intangible cultural heritage shows, cultural performances and consumer benefit activities.

In addition to the local specialties, delicacies and handcrafted goods from Lancang-Mekong countries have also been available.

When international guests sat down with local inheritors to discuss craftsmanship and farm produce, the Lancang-Mekong Cooperation vision of extensive consultation, joint contribution and shared benefits was no longer confined to written documents, but embodied in every tasting and face-to-face dialogue.

It is noted that for more than 30 years, the Culture and Art Festival of Countries in the Lancang-Mekong River Basin has served as a vital bond connecting peoples across the basin. The carnival is an extension of the festival, representing a bridge crossing language barriers.

Leveraging the festival platform, Xishuangbanna will continue to make good use of this waterborne link to further promote people-to-people exchanges.

Original link: https://en.imsilkroad.com/p/352765.html

SOURCE Xinhua Silk Road

Share this article

Envision's Tianji Weather Foundation Model Tops ECMWF's AI Weather Quest, Setting a New Global Benchmark for Physics-AI Forecasting

SHANGHAI, Oct. 30, 2026 /PRNewswire/ -- Envision, a global leader in green technology, today announced that its independently developed weather foundation model, Envision Tianji, ranked first overall in the latest edition of the AI Weather Quest, an AI weather competition organized by the European Centre for Medium-Range Weather Forecasts (ECMWF). Tianji outperformed nearly 20 top teams worldwide, taking first place across all assessed metrics, including variable-averaged, near-surface temperature, mean sea level pressure, and precipitation for the 19â25 day forecast window.

The AI Weather Quest evaluates models through continuous, real-time forecasting and verification, assessing sustained performance under varying weather conditions. Beyond the 15-day medium-range forecast horizon, the competition focuses on probabilistic forecasts of weekly mean temperature and mean sea level pressure, and weekly accumulated precipitation, for days 19â25. Temperature and precipitation are evaluated over predominantly land-covered grid cells, while mean sea level pressure is assessed globally, emphasizing the ability to anticipate weekly conditions and their uncertainty several weeks in advance. Teams submit forecasts weekly, and organizers evaluate them against subsequent actual weather, publicly updating the leaderboard.

This win follows a series of top-tier results for Tianji, including a top-tier placement in the global WeatherBench 2 evaluation, on par with Google WeatherNext2 Model, and first place overall in the deterministic forecast track of the AI Weather Forecast Model Demonstration Program organized by China's National Meteorological Center. Tianji has also proven its value in energy applications, winning first place in State Grid's AI load forecasting competition and China Southern Power Grid's business competition. With this latest result, Envision has again demonstrated Tianji's full-chain capability, from short-term forecasting to subseasonal prediction.

"Subseasonal forecasting â two weeks to two months out â is one of the hardest challenges in meteorology," said Robert Zheng, head of Envision's Tianji Weather Foundation Model. "The longer the horizon, the greater the uncertainty in atmospheric changes, and the higher the demand on a model's ability to identify evolving weather trends. Building on Envision's years of practical experience in new energy, we have developed the world's first physics-AI weather model, leveraging petabyte-scale high spatiotemporal resolution data and a 'spaceâairâground' three-dimensional data network to deliver reliable forecasts across full time scales."

Powered by high-performance computing, Tianji delivers rapid short-term and global forecasts with significantly improved accuracy for wind speed and irradiance in key regions. Covering full time scales from minute-level nowcasting to subseasonal trend assessment, it provides end-to-end meteorological intelligence for real-time monitoring and long-term planning.

SOURCE Envision Energy

Share this article

DELRAY BEACH, Fla., Oct. 30, 2026 /PRNewswire/ -- According to MarketsandMarketsâ¢, the LEO satellites market is estimated at USD 12.82 billion in 2026 and is projected to reach USD 43.37 billion by 2031 at a CAGR of 27.6% during the forecast period.

Browse 300 market data Tables and 100 Figures spread through 350 Pages and in-depth TOC on 'LEO Satellite Market - Global Forecast to 2031'

LEO Satellite Market Size & Forecast:

- Market Size Available for Years: 2021â2031

- 2026 Market Size: USD 12.82 billion

- 2031 Projected Market Size: USD 43.37 billion

- CAGR (2026â2031): 27.6%

LEO Satellite Market Trends & Insights:

- The LEO satellites market is growing as satellite networks expand for communication, Earth observation, navigation, and defense applications. Developments in small satellite platforms, software-defined payloads, optical communication, and onboard data processing are helping operators improve coverage, reduce latency, and support a wider range of missions in low Earth orbit.

- By satellite mass, Small satellites are the fastest-growing segment due to the increasing deployment of LEO constellations for broadband communication, Earth observation, and defense applications. Their lower development and launch costs, shorter manufacturing cycles, and ability to be deployed in large constellations are supporting adoption among commercial operators, government agencies, and defense organizations.

- By application, Navigation satellites are the fastest-growing segment due to the rising demand for more accurate positioning, navigation, and timing services across transportation, defense, aviation, maritime, and autonomous systems. Increasing deployment of LEO-based navigation and PNT augmentation systems, along with the need for lower latency, stronger signal availability, and greater resilience than traditional navigation architectures, is supporting segmental growth.

- By customer type, Defense is the fastest-growing segment due to the increasing use of LEO satellites for secure communications, ISR, navigation support, and persistent monitoring. Rising defense investment in resilient space architectures, proliferated LEO constellations, and low-latency satellite networks is supporting adoption across military forces and defense agencies.

- By region, the Middle East is the fastest-growing region in the LEO satellites market, driven by rising investment in satellite communications, Earth observation, defense surveillance, and national space programs. Growing demand for secure connectivity across remote areas, expanding defense and border-monitoring requirements, and new satellite initiatives in countries such as the UAE and Saudi Arabia are supporting regional market growth due to increasing investment in drone detection across military bases, airports, borders, and critical infrastructure. Growing concerns around unauthorized drone activity and continued deployment of radar, RF, EO/IR, and multi-sensor systems are supporting regional growth.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=252330251

LEO satellite operators are creating sustained demand through frequent replenishment and replacement of spacecraft. Satellites in low Earth orbit usually have shorter operating lives than larger satellites in higher orbits. Constellations therefore require regular launches to replace aging satellites, to maintain coverage and introduce upgraded payloads. Operators can also refresh technology faster as communication, processing and sensing requirements change. Planned deorbiting and debris mitigation requirements further increase the need for replacement satellites over time. This creates recurring demand for satellite platforms, propulsion systems, power systems, antennas and payloads. Large constellations also support repeat production, which allows manufacturers to maintain continuous assembly lines and improve production efficiency globally.

By customer type, the commercial segment is estimated to hold the second-largest market share in 2026.

The segment is supported by the growing deployment of LEO constellations for broadband, Earth observation, direct-to-device connectivity and data services. Commercial operators are benefiting from the scalable networks that allow capacity to be added as demand grows. Moreover, they also use standardized satellite buses and high-rate production to reduce costs and shorten deployment timelines. Large programs such as SpaceX Starlink and Amazon Project Kuiper are increasing satellite volumes and replacement demand. Earth observation companies are also deploying smaller satellites with shorter refresh cycles. These factors are supporting steady commercial demand across LEO satellite platforms, payloads, and related subsystems.

By frequency band, laser/optical band is expected to be the fastest-growing segment between 2026 and 2031.

The segment is expected to grow rapidly as LEO operators increase the use of optical inter-satellite links for high-capacity data transfer. Laser links allow satellites to exchange data directly in space without routing every transmission through ground stations. This reduces latency and improves network resilience. Optical links also avoid congestion in traditional RF spectrum and support higher data rates. Large constellations are increasingly adopting this architecture to move traffic across the network more efficiently. For instance, SpaceX Starlink is launching newer satellites using laser crosslinks for satellite-to-satellite communication.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=252330251

Europe is projected to be the largest LEO satellites industry during the forecast period.

Europe is expected to hold the largest market share due to strong government support, established satellite manufacturing capabilities, as well as growing sovereign connectivity programs. The region has a well-developed space ecosystem which is led by companies like Airbus, Thales Alenia Space, OHB, and Eutelsat OneWeb. Programs such as IRIS² are supporting the development of resilient satellite connectivity across the region. Europe also benefits from strong participation in ESA programs and a mature network of satellite subsystem suppliers. These factors are supporting sustained demand for LEO satellite platforms, payloads, and related subsystems.

Key Players in LEO satellites companies such as SpaceX (US), L3Harris Technologies (US), Lockheed Martin (US), Northrop Grumman (US), and Airbus Defence and Space (Netherlands).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=252330251

Browse Adjacent Market: Aerospace and Defence Market Research Reports &Consulting

See More Latest Aerospace and Defence Reports:

Solar Powered Drone Market Size, Share and Trends by Energy Architecture (Fully Solar-Electric UAV, Solar-Assisted Battery UAV), Drone Type (Small, Medium, Large), Operating Altitude, Application, and Region - Global Forecast to 2035

Space Cybersecurity Market Size, Share and Trends by Offering (Solutions (Network, Endpoint, Cloud, Application Security), Services), Platform (Satellites, Launch Vehicles, Ground Stations & Gateways), End User, Application, and Region - Global Forecast to 2031

About MarketsandMarketsâ¢

MarketsandMarkets⢠has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets⢠is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines â TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStoreâ¢, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets⢠SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarketsâ¢.com or follow us on Twitter, LinkedIn and Facebook.

Contact:

Mr. Rohan Salgarkar

MarketsandMarkets⢠INC.

1615 South Congress Ave.

Suite 103, Delray Beach, FL 33445

USA: +1-888-600-6441

Email: [email protected]

Visit Our Website: https://www.marketsandmarkets.com/

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/leo-satellite-market.asp

Content Source: https://www.marketsandmarkets.com/PressReleases/leo-satellite.asp

SOURCE MarketsandMarkets

Share this article

Popular Hot Deals program in the Southeast inspires a broader evolution of Rural King Rewards, with new benefits and exclusive offers on the way

MATTOON, Ill., Oct. 30, 2026 /PRNewswire/ -- Rural King, a family-owned retailer dedicated to the rural lifestyle, is giving customers more ways to save with a major refresh of its Rural King Rewards loyalty program. Building on the popularity of its Hot Deals initiative in the Southeast, the retailer is introducing an enhanced Rewards experience designed to deliver more exclusive savings, special offers and everyday benefits to members at Rural King Stores nationwide.

The changes begin Nov. 1 and reflect Rural King's continued commitment to helping customers stretch their dollars further while making it easier and more rewarding to shop for the products they need.

"Our customers have told us they want more ways to save, and we've been listening," said Alex Melvin, chairman of Rural King. "The response to Hot Deals in the Southeast showed us just how much our customers value meaningful savings on everyday essentials. Now we're taking that same approach and building a better Rewards experience for all our members, no matter where they shop."

Launched in September at participating Rural King stores in Florida, Alabama and Georgia, the Hot Deals program offered members steep discounts on 10 everyday essentials, including pet food, livestock feed, household supplies and automotive products. The initiative focused on delivering meaningful savings on products customers regularly purchase, with prices at least 25% below normal market prices.

The positive response helped shape Rural King's broader vision for its loyalty program, extending the emphasis on everyday value beyond a select group of stores and products.

Under the refreshed Rural King Rewards program, members can look forward to several enhanced benefits, including:

- Members-only pricing and sales: Exclusive opportunities to save on products throughout the store.

- Birthday and membership anniversary rewards: Special perks to recognize and celebrate loyal customers.

- Early access to sales and events: Opportunities for members to access select promotions and events early.

- Easier purchase lookup and returns: A more convenient shopping experience with simplified access to purchase records.

"We want Rural King Rewards to be about more than earning points," Melvin said. "It's about giving our customers real value, whether that's a better price on something they need, early access to a great sale or a special reward just for being a member. We want every visit to Rural King to be worth more."

As part of the transition, members will no longer earn points on eligible purchases under the base Rural King Rewards loyalty program beginning Nov. 1. Any remaining points that have not been converted into rewards will expire. Previously issued rewards will remain valid for 60 days from their issuance dates and can be redeemed in stores or online, subject to program terms. Rural King Visa cardholders will continue to earn points through the Rural King Visa Rewards program.

Beginning Nov. 1, 10 Hot Deals will be available at Rural King stores nationwide, with additional benefits rolling out in phases.

Rural King Rewards is free to join. Customers can visit RuralKing.com for updates or help.RuralKing.com for assistance with their membership.

For more information, visit Ruralking.com, RKguns.com or RKtractors.com.

About Rural King, Inc.

Rural King, also known as RK Holdings, LLP, planted its roots as America's Farm and Home Store in Mattoon, Illinois, in 1960. Since that time, Rural King has grown to more than 160 stores in 18 states. Rural King offers the lowest prices on a broad range of essential goods, food, feed, seed and other farm and home necessities to the communities we serve throughout Alabama, Georgia, Florida, Illinois, Indiana, Kentucky, Maryland, Michigan, Mississippi, Missouri, North Carolina, New York, Ohio, Pennsylvania, South Carolina, Tennessee, Virginia, and West Virginia. We welcome and encourage everyone to enjoy our longstanding tradition of offering free popcorn and coffee every time you visit our stores.

SOURCE Rural King

Share this article

Millennium Dental Technologies Marks Major Milestone: 49% of Active American Academy of Periodontology Members Now Trained in the LANAP® Protocol

Growing Adoption Among Periodontists and General Dentists Expands Patient Access to Minimally Invasive Laser Procedure for Moderate to Severe Periodontitis

SEATTLE, Oct. 30, 2026 /PRNewswire/ -- Millennium Dental Technologies, Inc., the developer of the LANAP protocol and manufacturer of the PerioLase® MVP-7⢠variable-pulsed Nd:YAG dental laser, announced at the American Academy of Periodontology (AAP) Annual Meeting in Seattle today that 49% of the AAP's active membership in the United States are now LANAP-trained clinicians.

The milestone reflects the expanding adoption of the minimally invasive alternative to traditional osseous surgery for patients with moderate to severe periodontal disease. With approximately half of active AAP members now trained in the LANAP protocol, more patients have access to the procedure that helps save hopeless teeth while reducing the discomfort and recovery time associated with conventional periodontal surgery.

"Reaching 49% of active AAP members represents a major milestone, but its real significance is what it means for patients," said Robert H. Gregg II, DDS, Founder, President and Chairman of the Board of Millennium Dental Technologies. "Our mission has always been about the patientâhelping people save their natural teeth through a far less invasive treatment grounded in science. With more periodontists and general dentists trained in the LANAP protocol, patients have greater access to care they can feel comfortable accepting."

The announcement coincides with the 25-year anniversary of the PerioLase MVP-7⢠and the LANAP protocol's 10-year anniversary of FDA clearance for true periodontal regeneration. Supported by extensive scientific and human histological research, including 651 positive patient outcomes published since 1998, the LANAP protocol is clinically proven to regenerate the attachment apparatus lost to periodontal disease, including new cementum, periodontal ligament and alveolar bone on a previously diseased root surface.

Available only with the PerioLase MVP-7, the LANAP protocol uses laser energy to target harmful bacteria and diseased tissue while preserving healthy tissue. Treatment does not require scalpels or sutures and is a more comfortable experience for patients with less bleeding and faster recovery than traditional osseous surgery, helping patients return to their daily activities sooner.

Patient acceptance is another important part of the protocol's impact. In an independent survey of 512 LANAP-trained clinicians published in Decisions in Dentistry, 91.5% of respondents rated patient treatment acceptance more positively with the LANAP protocol than with traditional periodontal treatment modalities.

Each LANAP-trained clinician undergoes extensive training at the Institute for Advanced Laser Dentistry (IALD), which combines didactic instruction with supervised treatment of live patients.

"Every LANAP-trained clinician goes through the IALD curriculum, including hands-on treatment of live patients under the supervision of certified instructors," said Dawn M. Gregg, DDS, Training Director of the IALD and Vice President of Operations at Millennium Dental Technologies. "Our program helps ensure doctors develop the clinical judgment and skills needed to deliver patient-centered care using the LANAP protocol and other laser procedures. As adoption grows, that commitment to education remains fundamental. That's one of the reasons we have been so successful in driving adoption among AAP members."

ABOUT MILLENNIUM DENTAL TECHNOLOGIES, INC.

Headquartered in Cerritos, Calif., Millennium Dental Technologies is the developer of the LANAP protocol for treating periodontal disease and the manufacturer of the PerioLase MVP-7 variable-pulsed Nd:YAG dental laser. The company's FDA-cleared LANAP protocol offers a more comfortable, less invasive alternative to conventional periodontal surgery while providing unique bone-building clinical results. Founding clinician Robert H. Gregg II, DDS, continues to lead the company with a vision to create better clinical outcomes for patients with periodontal disease while remaining true to its guiding principle: "It's all about the patient." For more information, visit www.lanap.com.

ABOUT THE INSTITUTE FOR ADVANCED LASER DENTISTRY

The Institute for Advanced Laser Dentistry is a nonprofit educational and research organization dedicated to advancing evidence-based clinical training in laser dentistry. Established in 1999, the IALD is nationally recognized for its continuing education programs as an ADA Continuing Education Recognition Program and Academy of General Dentistry Program Approval for Continuing Education provider. For more information, visit www.theiald.com.

SOURCE Millennium Dental Technologies, Inc.

Share this article

IL-23 inhibitor approved exclusively for healthcare provider-administered treatment

Expands use of ILUMYA beyond moderate-to-severe plaque psoriasis strengthening Sun Pharma's portfolio in psoriatic disease

MUMBAI, India and PRINCETON, N.J., Oct. 30, 2026 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associated companies) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ILUMYA® (tildrakizumab-asmn) for the treatment of adults with active psoriatic arthritis (PsA).

"FDA approval of ILUMYA for adults with active psoriatic arthritis represents another important innovative medicine milestone for Sun Pharma and builds on the established clinical experience of ILUMYA in plaque psoriasis," said Rick Ascroft, North America CEO, Sun Pharma. "As an IL-23 inhibitor administered exclusively by a healthcare provider, ILUMYA is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment or who may benefit from regular in-office care."

Approximately 2.4 million Americans live with psoriatic arthritis, which can cause joint pain, swelling and stiffness that may lead to permanent joint damage. The approval expands the use of ILUMYA, an IL-23 inhibitor approved by the FDA in 2018 for the treatment of adults with moderate-to-severe plaque psoriasis (PsO) who are candidates for systemic therapy or phototherapy.

"Psoriatic arthritis is a complex and chronic disease. As clinicians, we need a range of therapeutic options that allow us to individualize care based on each patient's symptoms and treatment goals. Adding an IL-23 inhibitor option that is administered by a healthcare provider gives us a new way to offer appropriate patients additional support and engagement with their healthcare team," said Philip Mease, Director of Rheumatology Research at the Swedish Medical Center and Providence St Joseph Health and Clinical Professor at the University of Washington School of Medicine, Seattle, WA.

The approval is supported by Phase 3 INSPIRE-1 and INSPIRE-2 clinical studies, which evaluated the efficacy and safety of ILUMYA after only two doses at 24 weeks in adult patients with active psoriatic arthritis.

Safety data in the studies was consistent with the well-documented safety profile of ILUMYA. No new safety signals were identified in the INSPIRE-1 and INSPIRE-2 studies. ILUMYA may increase the risk of infection. Patients should be evaluated for tuberculosis (TB) infection prior to initiating treatment. Most common adverse reactions are: Plaque Psoriasis (â¥1%): upper respiratory infections, injection site reactions, and diarrhea. Psoriatic Arthritis (â¥3%): upper respiratory tract infections and COVID-19.

About the INSPIRE-1 and INSPIRE-2 Phase 3 Studies

INSPIRE-1 and INSPIRE-2 are 52-week, global, multicenter, randomized, double-blind, placebo-controlled Phase 3 studies evaluating the efficacy and safety of tildrakizumab 100 mg (ILUMYA) in adults with active psoriatic arthritis.

Learn more about the studies at clinicaltrials.gov (INSPIRE-1 NCT04314544 and INSPIRE-2 NCT04314531).

About Psoriatic Arthritis (PsA)

Psoriatic arthritis (PsA) is a chronic (long-lasting or recurring) disease related to the immune system. It causes swelling, pain, and stiffness in joints and entheses (places where tendons and ligaments connect to bones).1 Psoriatic arthritis can develop at any age.2 Psoriatic arthritis can occur regardless of the severity of psoriasis (mild, moderate, or severe). Roughly 1 in 3 people living with psoriasis also have psoriatic arthritis3; typically, with psoriasis developing before psoriatic arthritis.2 While as many as 2.4 million Americans live with psoriatic arthritis, more than 15% of people living with psoriasis may also have undiagnosed psoriatic arthritis.4

About ILUMYA® (tildrakizumab-asmn)

ILUMYA (tildrakizumab-asmn) is a humanized lgG1/k monoclonal antibody designed to selectively bind to the p19 subunit of interleukin-23 (IL-23) and inhibit its interaction with the IL-23 receptor, leading to inhibition of the release of pro-inflammatory cytokines and chemokines. ILUMYA is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy and for the treatment of adults with active psoriatic arthritis, in the United States. ILUMYA has also been approved for moderate-to-severe plaque psoriasis in India, Australia, Canada, China and Japan, and under the brand name ILUMETRI® in Europe, where it is marketed by Almirall.

ILUMYA is the 1st biologic to earn the National Psoriasis Foundation (NPF) Seal of Recognition. The NPF Seal recognizes products that meet the Foundation's established review criteria and reflects Sun's continued commitment to supporting people living with psoriatic disease.

INDICATION

ILUMYA® is indicated for the treatment of:

- moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

- active psoriatic arthritis in adult patients.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

ILUMYA is contraindicated in patients with a history of serious hypersensitivity reaction to tildrakizumab or to any of the excipients.

WARNINGS AND PRECAUTIONS

Hypersensitivity: Cases of angioedema and urticaria occurred in ILUMYA treated subjects in clinical trials. If a serious allergic reaction occurs, discontinue ILUMYA immediately and initiate appropriate therapy.

Infections: ILUMYA may increase the risk of infection. Treatment with ILUMYA should not be initiated in patients with any clinically important active infection until the infection resolves or is adequately treated. In patients with a chronic infection or a history of recurrent infection, consider the risks and benefits prior to prescribing ILUMYA. Instruct patients to seek medical help if signs or symptoms of clinically important chronic or acute infection occur. If a patient develops a clinically important or serious infection or is not responding to standard therapy, monitor the patient closely and consider discontinuation of ILUMYA until the infection resolves.

Tuberculosis: Evaluate patients for tuberculosis (TB) infection prior to initiating treatment with ILUMYA. Do not administer ILUMYA to patients with active TB infection. Initiate treatment of latent TB prior to administering ILUMYA. Monitor patients for signs and symptoms of active TB during and after ILUMYA treatment. Consider anti-TB therapy prior to initiation of ILUMYA in patients with a history of latent or active TB in whom an adequate course of treatment cannot be confirmed.

Immunizations: Prior to initiating therapy with ILUMYA, consider completion of all age appropriate immunizations according to current immunization guidelines. Avoid the use of live vaccines in patients treated with ILUMYA.

ADVERSE REACTIONS

Most common adverse reactions associated with ILUMYA treatment are:

- Plaque Psoriasis (â¥1%): upper respiratory infections, injection site reactions, and diarrhea.

- Psoriatic Arthritis (â¥3%): upper respiratory tract infections and COVID-19.

USE IN SPECIFIC POPULATIONS

Pregnancy

Advise patients that there is a pregnancy exposure registry that monitors outcomes in women exposed to ILUMYA during pregnancy.

Patients can enroll by calling MotherToBaby at 1-866-626-6847 or by visiting

https://mothertobaby.org/ongoing-study/ilumya-tildrakizumab-asmn.

Please see Full Prescribing Information.

About Sun Pharmaceutical Industries Limited (CIN - L24230GJ1993PLC019050):

Sun Pharma is the world's leading specialty generics company with a presence in innovative medicines, generics and consumer healthcare products. It is the largest pharmaceutical company in India and is a leading generic company in the U.S. as well as global Emerging Markets. Sun Pharma's high-growth global Innovative Medicines portfolio spans innovative products in dermatology, ophthalmology, and onco-dermatology and accounts for about 20% of company sales. The company's vertically integrated operations deliver high-quality medicines, trusted by physicians and consumers in over 100 countries. Its manufacturing facilities are spread across six continents. Sun Pharma is proud of its multicultural workforce drawn from over 50 nations. For further information, please visit www.sunpharma.com and follow us on LinkedIn & X (Formerly Twitter).

Disclaimer

Statements in this "Document" describing the Company's objectives, projections, estimates, expectations, plans or predictions or industry conditions or events may be "forward looking statements" within the meaning of applicable securities laws and regulations. Actual results, performance or achievements could differ materially from those expressed or implied. The Company undertakes no obligation to update or revise forward-looking statements to reflect developments or circumstances that arise or to reflect the occurrence of unanticipated developments/circumstances after the date hereof.

Contacts: Sun Pharma

© 2026 Sun Pharmaceutical Industries, Inc. All Rights reserved.

SOURCE Sun Pharma

Share this article